Cognitive behavioral therapy and emotion-focused therapy for depression in a routine care setting: A randomized controlled pilot trial.

Psychother ResOct 1, 2025 (epub)
Clinical ResearchPsychiatry

Hanna Aardal, Elisabeth Schanche, Aslak Hjeltnes et al.

✦ AI-curated · Sources linked

In 30 seconds

This pilot, parallel-group randomized controlled trial compared cognitive behavioral therapy (CBT) with emotion-focused therapy (EFT) for adults with major depression in a Norwegian routine-care mental health program. Participants were assigned to 9–18 sessions, with depressive symptoms assessed after treatment and at 3-, 6-, and 12-month follow-ups. Symptoms improved significantly from baseline through follow-up (BDI-II, d = 0.56; 95% CI: 0.45, 0.66). The trial found no significant difference between therapies, but its small sample limits conclusions about comparative effects.

Key findings

  • Depressive symptoms improved from baseline through follow-up (BDI-II, d = 0.56; 95% CI: 0.45, 0.66).
  • No significant symptom differences were detected between CBT and EFT; the small sample precludes definitive comparative conclusions.
  • Overall dropout was 6.31% (CBT: 10.91%, EFT: 1.79%).

Why it matters

The trial provides preliminary evidence that both CBT and EFT can be delivered in a Norwegian routine-care program for major depression, with symptom improvement and low overall dropout. The absence of a detected difference may inform further comparative research, but the pilot sample is not sufficient to establish that the therapies have equivalent effects.

What to keep in mind

This was a pilot trial with a small sample, limiting definitive conclusions about differences between treatments.

Source

Published in Psychother Res. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.